Transforming Health in Singapore through Precision Medicine
Coordinate a whole of government effort to implement Singapore’s National Precision Medicine programme, to drive at the national level: data-driven healthcare, improved patient outcomes and economic value capture.
Precision Health Research, Singapore (PRECISE)is the central entity set up to coordinate a whole of government effort to implement Phase II of Singapore’s 10-year National Precision Medicine (NPM) strategy.
NPM Phase II aims to transform healthcare in Singapore and improve patient outcomes through new insights into the Asian genome and data-driven healthcare solutions. NPM Phase II will also enhance the breadth and depth of the Precision Medicine-related industry by attracting and anchoring overseas companies in Singapore while yielding new opportunities for home-grown companies.